Survival of Vaccine-Induced Human Milk SARS-CoV-2 IgG, IgA and SIgA Immunoglobulins across Simulated Human Infant Gastrointestinal Digestion인간 유아 위장 소화를 통한 백신 유도 모유 SARS-CoV-2 IgG, IgA 및 SIgA 면역글로불린의 생존Article Published on 2022-08-172022-09-12 Journal: Nutrients [Category] SARS, 진단, [키워드] adenovirus-based antibody Breastfeeding breastmilk COVID-19 COVID-19 pandemic Degradation digestion dose evaluated Evidence Gastrointestinal GI Tract help Human human milk IgA IgA antibody IgG Immunoglobulin immunoglobulins in vitro Inconclusive Infant information intestinal lactating milk mother mRNA-based vaccine natural infection passive immunity persistence Pfizer/BioNTech produced PROTECT protective role protocol recent reduced reduction SARS-CoV-2 SARS-CoV-2 IgG secretory IgA SIgA the SARS-CoV-2 virus the spike protein the vaccine transfer vaccination Vaccine women [DOI] 10.3390/nu14163368 PMC 바로가기 [Article Type] Article
Diagnostic Performance of Three ELISAs for Detection of Antibodies against SARS-CoV-2 in Human Samples인간 샘플에서 SARS-CoV-2에 대한 항체 검출을 위한 3가지 ELISA의 진단 성능Article Published on 2022-08-162022-09-11 Journal: The Scientific World Journal [Category] SARS, 진단, 치료기술, 치료법, [키워드] Accuracy acute respiratory syndrome acute respiratory syndrome coronavirus antibody production Antibody responses Antigen antigens approach cause Cohort coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 detection determine Diagnosis disease ELISA ELISAs evaluated fraction Human IgG immunoassay immunoassays Immunoglobulin Immunoglobulin G immunological indicated Infection N protein nucleocapsid patients performance Protein RBD Receptor binding domain respiratory Sample SARS-CoV-2 SARS-CoV-2 infections sensitivities sensitivity serological test Serological tests severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Specificities specificity Spike protein subject the antibody response the N protein Transmission [DOI] 10.1155/2022/7754329 PMC 바로가기 [Article Type] Article
AYURAKSHA, a prophylactic Ayurvedic immunity boosting kit reducing positivity percentage of IgG COVID-19 among frontline Indian Delhi police personnel: A non-randomized controlled intervention trialClinical Trial Published on 2022-08-162022-10-04 Journal: Frontiers in Public Health [Category] SARS, 임상, 진단, [키워드] Analysis Anu AYURAKSHA kit Ayurveda Blood blood sugar C-reactive protein CD3 CD4 CD8 clinical control group controls COVID-19 COVID-19 crisis COVID-19 infection COVID-19 pandemic determine distribution dysregulated effective Efficacy effort erythrocyte sedimentation rate evaluated hematological hematological parameter hematological parameters IgG IgG positivity IL-6 IL-6 level Immunity incidence India Infection inflammation marker Intervention life lower risk Lymphocyte subset management Medicine Mortality no increase non-randomized pandemic participant Participants post-intervention Primary outcome Prophylactic Quality Quality of life Quality of life (QoL) random reduced reducing Research secondary outcome severity of COVID-19 significantly significantly lower status the WHO Trial Version [DOI] 10.3389/fpubh.2022.920126 PMC 바로가기 [Article Type] Clinical Trial
Two-years antibody responses following SARS-CoV-2 infection in humans: A study protocol인간에서 SARS-CoV-2 감염 후 2년 항체 반응: 연구 프로토콜Article Published on 2022-08-162022-09-12 Journal: PLoS ONE [Category] SARS, 진단, [키워드] 95% confidence interval anti-SARS-CoV-2 antibody antibody kinetics Antibody Response association Characteristics Clinical data CMIA Cohort collected Community control group controls cumulative determine disease severity IgG IgM Indonesia infected patient Infection information Kaplan-Meier method Logistic regression non-infected observé Odds ratio Patient protective factor Protein RBD of SARS-CoV-2 recruit risk risk factor RT-PCR SARS CoV-2 SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 patient seroconversion rates serum sample Study protocol tested the SARS-CoV-2 Transmission used to calculate variables [DOI] 10.1371/journal.pone.0272690 PMC 바로가기 [Article Type] Article
Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV 및 mRNA-1273을 사용한 SARS CoV-2에 대한 이종 면역의 면역원성과 반응성Article Published on 2022-08-162022-09-11 Journal: Cell Reports Medicine [Category] SARS, 변종, 진단, 치료기술, [키워드] Ad5-nCoV analyzed Anti-spike Antibody Response BBIBP-CorV ChAdOx1 ChAdOx1 vaccine ChAdOx1-S Cohort Combination coronavirus disease Coronavirus disease 2019 Coverage COVID-19 evaluate Heterologous heterologous vaccination heterologous vaccine highest homologous humoral Humoral response IgG immunization immunogenicity Immunoglobulin Immunoglobulin G information Messenger RNA mRNA mRNA-1273 nCoV Neutralizing antibodies observation observé omicron Omicron variant Participants platform provide reactogenicity Region SARS CoV-2 SARS-CoV-2 second dose Serious Adverse Event Serious Adverse Events Sputnik V Support titers vaccination Vaccine virus neutralizing titer virus neutralizing titers [DOI] 10.1016/j.xcrm.2022.100706 PMC 바로가기 [Article Type] Article
Platform for Active Vaccine Formulation Using a Two-Mode Enhancement Mechanism of Epitope Presentation by Pickering Emulsion피커링 에멀젼에 의한 에피토프 제시의 2-모드 향상 메커니즘을 사용한 활성 백신 제형을 위한 플랫폼Article Published on 2022-08-152022-09-12 Journal: ACS applied bio materials [Category] SARS, 진단, [키워드] Administered ambient antigenic Antisera applied approach Concentration conditions conjugate correlated determinants Efficacy Efficiency Emulsion enhancement epitope epitope-based vaccination Formulation heterogeneity IgG IgG titer Immunoglobulin include magnitude Pathogens peptide Pickering emulsion plant virus platform presentation subsequent subunit subunit vaccines vaccination Vaccine development Virus-like-particles. vivo assay VLPs [DOI] 10.1021/acsabm.2c00410 PMC 바로가기 [Article Type] Article
Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesisArticle Published on 2022-08-152022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] acute respiratory syndrome addition anti-SARS-CoV-2 antibody Antibody-dependent enhancement antigenic bleeding controls coronavirus COVID-19 COVID-19 patient cross-protection cross-react cross-reactive antibody cross-reactivity dengue patient dengue virus Diagnosis disease disease severity domain endothelial envelope protein epitope False-positive hyperimmune IgG in vitro induce Infection inhibited mice Neutralizing nonstructural protein 1 passive transfer Pathogenesis peptide promote purified random reaction reduced reported SARS-CoV-2 SARS-COV-2 infection sera serology test significantly increased Spike protein Spread the SARS-CoV-2 [DOI] 10.3389/fimmu.2022.941923 PMC 바로가기
Vaccination against SARS-CoV-2 in Haemodialysis Patients: Spike’s Ab Response and the Influence of BMI and Age혈액 투석 환자의 SARS-CoV-2 예방 접종: Spike의 Ab 반응과 BMI 및 연령의 영향Multicenter Study Published on 2022-08-152022-09-12 Journal: International Journal of Environmental Research an [Category] SARS, 진단, [키워드] age antibody BMI BNT162b2 mRNA body mass index carried Chronic kidney disease Cohort cohort of patient Complete composed control group correlation COVID-19 declined dialysis Elderly patient faster greater groups humoral Humoral response identify IgG IgG antibody immune response immune system Immunity influence median multicenter older patient participant Patient Pfizer-BioNTech Portugal response SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection selected serum significantly spike the median titres vaccination Vaccine younger patient [DOI] 10.3390/ijerph191610091 PMC 바로가기 [Article Type] Multicenter Study
Clinical and immunological features associated to the development of a sustained immune humoral response in COVID-19 patients: Results from a cohort studyArticle Published on 2022-08-152022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] abnormality acute infection acute respiratory syndrome anti-cellular antibodies anti-SARS-CoV-2 IgG antibodies antibody Antibody Response Antiviral baseline blood sample CD8 changes in characterized chemokine chemokines clinical cohort study coronavirus coronavirus disease COVID-19 Critical Critical disease Critical illness cytokine Cytokines defined Diagnosis evaluated feature flow cytometry Follow-up humoral humoral immune response Humoral response IgG IgGs IL-13 IL-2 IL-4 immune Immune profile immunological IP-10 key factor lymphocyte Lymphocytes lymphopenia Measures Neutrophil extracellular trap outcome Patient patients with COVID-19 positive Primary outcome Quantitative recruitment regulatory T cells Research Result SARS-CoV-2 serum serum cytokine Serum level serum titer strongly related sustained T cell T cells the patient variable were assessed [DOI] 10.3389/fimmu.2022.943563 PMC 바로가기
Equipment-free, gold nanoparticle based semiquantitative assay of SARS-CoV-2-S1RBD IgG from fingertip blood: A practical strategy for on-site measurement of COVID-19 antibodies손끝 혈액에서 SARS-CoV-2-S1RBD IgG의 장비가 필요 없는 금 나노입자 기반 반정량적 분석: COVID-19 항체의 현장 측정을 위한 실용적인 전략Article Published on 2022-08-152022-09-11 Journal: Talanta [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] antibodies antibody AuNR Colorimetric reagent complementary correlated COVID-19 COVID-19 antibody declined ELISA assay estimation fingertip Fingertip blood gold Gold nanoparticle IgG IgG antibody Immunoglobulin Immunoglobulin G implementation management pandemic plate reader provide quantitation RBD Receptor binding domain revaccination SARS-CoV-2 semi-quantitative Serum neutralizing antibody SRAS-CoV-2 vaccination [DOI] 10.1016/j.talanta.2022.123498 PMC 바로가기 [Article Type] Article